Xuefei Li

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Fengying Wu, Jue Fan, Yayi He et al. · Nature Communications · 2021 · 759 citations · Full text

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

Sha Zhao, Shengxiang Ren, Tao Jiang et al. · Cancer Immunology Research · 2019 · 329 citations

Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer

Xiaomei Gong, Xuefei Li, Tao Jiang et al. · Journal of Thoracic Oncology · 2017 · 294 citations

Cancer Immunosurveillance, Medicine, Immunology +6

Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs

Qinghua Xu, Fei Zhou, Hui Liu et al. · Journal of Thoracic Oncology · 2018 · 194 citations

Oncology, First-line Egfr-tkis, Pathology +3

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

Bing Li, Shengxiang Ren, Xuefei Li et al. · Lung Cancer · 2013 · 175 citations

Tumor Biology, Oncology, Medicine +10